The Pathway to Operational Excellence in the Pharmaceutical Industry: Overcoming the Internal Inertia
- ISBN-10
- 3871934003
- ISBN-13
- 9783871934001
- Category
- Drug development
- Pages
- 365
- Language
- German
- Published
- 2010
- Author
- Thomas Friedli
Description
Neue Technologien, sich wandelnde Geschäftsstrategien, Kostendruck auf Hersteller und Zulieferer, migrierende globale Wertschöpfungsketten sowie neue regulatorische Anforderungen sind die Herausforderungen der Pharmaindustrie. Um in allen Bereichen Exzellenz zu erreichen gilt es, den Fokus auf die Menschen zu richten. Sie planen, bewirken, verbessern und erfinden neue Strategien, erfahren, Systeme und Strukturen. Die Fähigkeit zur Überwindung der inneren Trägheit eines Unternehmens macht den Unterschied. Die höchsten FundE-Ausgaben verzeichneten die Unternehmen, die sich nicht weiter mit einem eingeführten und evaluierten Verfahren beschäftigten. Das beeinträchtigte Innovationen im Produkt- und Substanzbereich. Veränderungen werden an Geschwindigkeit und Umfang zunehmen. Hier setzt die Operational Excellence ein. Dies impliziert, das Herstellungspotenzial zu entwickeln, als Grundlage einzigartiger Geschäftsstrategien. Dazu erforderlich sind Exzellenz in Führung und Management, Methoden und Tools sowie Technologie und Innovation. Zielgruppen:- Pharmazeutische Industrie- Zulieferindustrie- Fachhochschulen / Universitäten- Beratungsunternehmen- Behörden.
Get the book
Similar books
-
Private Profits versus Public Policy: The Pharmaceutical Industry and the Canadian State
By Joel LexchinAvailable from: http://www.cihr-irsc. gc.ca/e/34742.html. Bernstein A. Toward effective Canadian public-private partnerships in health research. CMAJ. ... Tyers M, Brown E, Andrews DW, et al. Problems with co-funding in Canada. Science.
-
Systems Thinking in Medicine and New Drug Discovery
By Robert E. SmithThis book will appeal to specialists, who will find recommendations on safer materials for 3D bioprinting and ways to analyze dietary supplements for toxic contaminants, and physicians, pharmacists and non-professionals, who will learn the ...
-
Synthetic Methods in Drug Discovery: Volume 1
By David C. Blakemore, Paul M. Doyle, Yvette M. FobianWhat are the current industrial research problems and how can they be resolved in an industrial setting? This book highlights key methods that have real impact in drug discovery and facilitate delivery of drug molecules.
-
Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry
By Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa VaidyanathanThe chapters in this book are written to accentuate the interdependency and synergy between drug discovery and process development disciplines to advance a new chemical entity into clinical trials and eventually to the market.
-
Design and Delivery of SiRNA Therapeutics
By Henrik J. Ditzel, Martina Tuttolomondo, Sakari KauppinenThis volume details protocols on rationale design of therapeutic siRNA molecules and its encapsulation with smart vehicles to overcome the barriers to an effective administration in vivo.
-
Drug Target Selection and Validation
By Marcus T. Scotti, Carolina L. BelleraConcepts and case studies in chemical biology. John Wiley & Sons, Inc.; 2014. Pai MY, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol. 2015;1263:287–98. Rock FL, et al.
-
Burger's Medicinal Chemistry, Drug Discovery and Development
By Donald J. AbrahamBringing in a new and expert editorial board, this new edition updates existing chapters and adds 35 new ones, with topics including: opioid addiction treatments, antibody and gene therapy for cancer, blood-brain barrier, HIV treatments, ...
-
Pharmacological Research on Traditional Herbal Medicines
By WantanabeIntroducing many pharmacological advances made, the work also describes the modern theories and scientific methodologies applied to today's studies on herbal medicines and new drug development.
-
Pharmaceutical Innovation: Revolutionizing Human Health
By Basil Achilladelis, Ralph Landau, Alexander ScriabineDocuments how science has provided an astonishing array of medicines for coping with human ailments. This volume addresses industry leaders, economic influences, and the development of individual products.
-
Capitalizing a Cure: How Finance Controls the Price and Value of Medicines
By Victor Roy... drug development. Soothing the “ups and downs” of finance that Gilead's founder, Riordan, had warned his employees about many years ago required a balm of its own sort, one not discovered in its laboratories but driven by Wall Street ...